Chalo pockets $45 mn from Avataar Ventures, others

Filter Capital has received capital commitments from a diverse investor base including Indian institutional investors and family offices such as HDFC Fund of Funds, HDFC AMC, SIDBI, SRI Fund, Oister Global, DSP family office, Akash Prakash, the founder of Amansa Capital, and Harsh Jain, the CEO of Dream11.

Capillary Technologies, a company that offers customer engagement and loyalty SaaS products and solutions to enterprises, on February 27 announced a fundraise of $95 million in a secondary deal for its ongoing Series D funding round. The new fundraise will offer exits to its existing shareholders.

Indian technology services industry is massive, with a vibrant start-up ecosystem. However, surprisingly the sector is not an area of focus for venture capital. Our co-founder Sumit Sinha, who has been investing in the space since the early 2000s pens a blog busting some of the myths surrounding the sector, making a case for venture investing in tech services.

Most Indian SaaS companies intend to expand into the US market. However successful market entry requires a compelling strategy. Over the past few years, Filter Capital’s portfolio company Capillary Technologies has laid the groundwork for its US market entry, culminating in its two recent acquisitions.

After closing its Series D fundraise of $45 mn from multiple investors including Filter Capital, Capillary completed its third acquisition in the US, acquiring Tenerity’s Digital Connect Assets.

Filter Capital, alongside a consortium of global investors, continues to extend its support to Capillary Technologies by participating in its Series D fundraise of $45 mn.

Filter Capital announced its fourth investment, in healthcare software company THB, partnering with Akansh Khurana and his team as they build Asia’s leading healthcare SaaS platform.

Last mile logistics services platform Loadshare raised a Series C round of Rs 300 Cr led by Tiger Global, with participation from Filter Capital, 57 Stars, and previous investors CDC and Matrix Partners India.